COMPASS Pathways PLC News - CMPS

Professional-Grade Tools, for Individual Investors.

Premium

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial...

Form 8-K - Current report

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Study met primary safety endpoint; administration was well tolerated, with no serious adverse events observed...

Form 4 - Statement of changes in beneficial ownership of securities

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology...

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

LONDON, April 29, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology...

Monksdream 3 months ago

CMPS new 52 week high

👍️0

Monksdream 4 months ago

CMPS new 52=week high

👍️0

Copilotdog 6 months ago

There will be no mushroom boom. The Fed’s will crush it. Shorting this to $3

👍️0

Monksdream 6 months ago

This podcast is an absolute screaming hilarious analysis of psycho stocks

👍️0

Monksdream 7 months ago

Uh, you know, we live now in technology driven world
In times past ever since the Industrial Revolution wealth was created primarily from natural resources
But that isn’t exactly the etched in stone fact
Prior to the mid-1850s there was the Scientific Revolution that began in the 1400s
The academic discipline of chemistry in some unforeseen way led to the accidental discovery by a Swiss chemist who walked to his lab well into his 80s
That said, as far as US stock market sectors are concerned, the medical sector is by far the largest in terms of the number of companies in which a retail or professional asset manager deploying other people’s money can invest
Close to 1 000 public traded companies
It is in my view pretty much a crap shoot when it comes finding one that is equivalent to Microsoft
With that said one should, in the long run, expect disappointment to be the norm rather than the exception

👍️0

LORTAP KCOTS 7 months ago

Last time I owned this, was when I sold it over $70, really dodged a bullet on this one.. unfortunately I own MNMD.. and it’s just as bad of a fall down shit show

👍️0

Monksdream 7 months ago

CMPS new 52 week low

👍️0

Monksdream 11 months ago

CMPS over $10

https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

👍️0

Monksdream 11 months ago

CMPS nearing resistance break it and it goes higher

👍️0

Denisnj 1 year ago

Definitely overpriced. Government needs slaves. No way they'll let humanity awaken

👍️0

starman2 2 years ago

https://investorplace.com/2022/07/dear-psychedelic-stocks-fans-watch-this-key-catalyst/

👍️0

starman2 2 years ago

https://www.benzinga.com/analyst-ratings/analyst-color/22/08/28522479/these-depression-players-are-hc-wainwrights-top-picks-for-400b-mental-healthcare-ma

(shared via bit.ly/mystocksapp)

👍️0

starman2 2 years ago

On fire.. So glad i jumped in.

👍️0

ListenToMe 2 years ago

Are you peeps watching PSYCF? I definitely think it's going to become the LEADER and Catalyst for the Mushroom sector!

👍️0

ListenToMe 2 years ago

Best mushroom play is PSYCF!!! Pay Attn.

.PSYCF

.

👍️0

ListenToMe 2 years ago

Awesome mushroom video & sound With its iconic red cap & white spots, our mushroom is the most recognizable mushroom in pop culture. It's often pictured in children's books, creating an association with magic and fairies, and tales told about the mushroom evoke an inner journey to the psyche.$PSYC $PSYC.C pic.twitter.com/XPTZXGY09C— Psyched Wellness (@PsychedWellness) January 5, 2022

👍️0

BesaoT35 3 years ago

Psychedelics are very safe drugs. A long term remission in treatment resistant major depression is a highly valuable and rare benefit to achieve for these patients.

On occasion there are reported cases of a psychosis induced, usually when that happens it is on very large doses of psychedelics perhaps combined with a non supportive environment.

Psilocybin causes fewer of these outcomes I have heard and is perhaps a less intense experience. Psilocybin is known to be a shorter acting psychedelic than LSD is.

Sedatives such as Valium or Xanax should be available if needed or desired at the end of the session in my opinion. Otherwise the process of coming down from the peak experience can be a drawn out and somewhat unpleasant process.

👍️0

LORTAP KCOTS 3 years ago

I love this stock!! Just flipped this for a $1500 profit in 24 hrs..

👍️0

BesaoT35 3 years ago

The clinical study for Treatment Resistant Major Depression looked very successful. Can a psychiatrist prescribe this patented psilocybin similar to how cannabis is illegal but medical doctors recommend it’s use legally for medical dispensaries?

How are they able to patent a known plant chemical? They claim to have a patented form of psilocybin.

👍️0

LORTAP KCOTS 3 years ago

Thank god I sold this.

👍️0

LORTAP KCOTS 3 years ago

This stock has really come back nicely!!

👍️0

LORTAP KCOTS 3 years ago

Awesome, just made $7700 on this trade!!!

👍️0

LORTAP KCOTS 3 years ago

Crushing upward today!!

👍️0

LORTAP KCOTS 3 years ago

Nice volume and nice price movement

👍️0

LORTAP KCOTS 3 years ago

This thing is moving up!!!

👍️0

LORTAP KCOTS 3 years ago

Big news today!!!

👍️0

LORTAP KCOTS 3 years ago

Steady increases, looks like we can get past $40 and then maybe $50?

👍️0

LORTAP KCOTS 3 years ago

WTF???

👍️0

Glider549 3 years ago

Sure was.
Schroom pharma is really advancing.

👍️0

LORTAP KCOTS 3 years ago

Nice movement today

👍️0

Tower of Hanoi 3 years ago

Nice interview. Now that ketamine therapy is in use, I really don't see any significant roadblocks to further expansion into other drugs.

Execution will be critical, plus how many competitors end up in the space.

👍️0

Investopotia 3 years ago

New CEO Interview

👍️0

Tower of Hanoi 3 years ago

I can't think of a better speculative space right now!

GLTA!

👍️0

Tower of Hanoi 3 years ago

Tiny, tiny position today:

10 shares @35.

Nice spec.

MY OPINION ONLY.

👍️0

0001-stocks 3 years ago

NEW BOARD!!! Psychedelic Stocks (link here)

https://investorshub.advfn.com/Psychedelic-Stocks-39490/

👍️0

ReviveThomas 3 years ago

I've eyeballed CMPS but not new to shroom stocks. What's the deal with this. Clinicaltrials.gov trial for treatment resistant depression in may ? Is that right?

👍️0

TRUSTUNITS1000000 3 years ago

Up 4.05

👍️0

TRUSTUNITS1000000 3 years ago

Going up

👍️0

TRUSTUNITS1000000 3 years ago

Could this we thousands dollar stock lollllll

👍️0

TRUSTUNITS1000000 3 years ago

Wowwwwwww

👍️0

WebSlinger 3 years ago

***PR OUT***

COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management team will participate in two investor conferences during the week of 11 January 2021.

George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will be participating in a fireside chat available on demand from 11 to 14 January in conjunction with the HC Wainwright BioConnect 2021 Conference.

George Goldsmith and Lars Wilde will also present a business update and hold a fireside chat at 12:15 pm ET on 14 January at the Westwicke Healthcare Day at the ICR Conference 2021.

Audio webcasts of the fireside chats will be available on the "Events" page of the Investors section of the COMPASS website at https://ir.compasspathways.com/news-events/events. A replay of events will be available for 30 days following the event.

https://www.globenewswire.com/news-release/2021/01/06/2154099/0/en/COMPASS-Pathways-plc-to-participate-in-HC-Wainwright-and-ICR-investor-conferences.html

👍️0

excboe 3 years ago

CMPS ARTICLE. Sketchy https://www.google.com/amp/s/qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/amp/

👍️0

TRUSTUNITS1000000 3 years ago

Wowwwwww so much cash

👍️0

WebSlinger 3 years ago

CMPS has $196.5 MILLION in cash (as of 30 Sep 2020)

That should hold them for about 4 years at the current burn rate of about $50 million per year.

https://sec.report/Document/0001628280-20-016249/

👍️0

Fress 3 years ago

Anxiety depression drug companies.
1.VTGN market cap $150 million 115 million in cash has Phase 3 & Phase 2's (Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
2 $CMPS2.0 BILLIION early trials 180 million cash
3 $MMED 1.1 BILLION phase 2 raised 40 million in cash
4 $SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline

$CMPS

👍️0

weedtrader420 3 years ago

CMPS $70 Target price this week

👍️0

weedtrader420 4 years ago

CMPS on the road to $100 woohooooooooo

👍️0

MomsSpaghetti 4 years ago

I am in this and MMEDF. Both of these are the horses.

👍️0

CHARLIE125 4 years ago

CMPS
OREGON legal.PSILOCIBIN WILL BE LEGAL THIS YEAR.
RUMOR IS OUT
PAYPAL ceo is buying more here

👍️0

AlphaStockNews 4 years ago

If you're watching $CMPS, you've gotta take a look at $SILO https://alphastocknews.com/silo-pharma-silo-stock-to-climb-on-planned-clinical-trial/4880/

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

COMPASS Pathways PLC (CMPS)

Professional-Grade Tools, for Individual Investors.

CMPS News

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

Form 8-K - Current report

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

CMPS Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

COMPASS Pathways PLC (CMPS) News

COMPASS Pathways PLC (CMPS)

Professional-Grade Tools, for Individual Investors.

CMPS News

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

Form 8-K - Current report

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

CMPS Discussion

Your Recent History

Company

Business

Popular

Get The App